Acellular matrix temperature-sensitive gel as well as preparation method and application thereof

By adding gallic acid or tannic acid as an irradiation protectant to the decellularized matrix thermosensitive gel, and combining it with freeze-drying and irradiation sterilization, the problem of collagen damage caused by irradiation sterilization is solved, achieving efficient protection of thermosensitive properties and industrial production, suitable for room temperature storage and rapid curing.

CN118924676APending Publication Date: 2024-11-12SHANDONG JUNXIU BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410626666.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-05-20
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

In existing technologies, decellularized matrix thermosensitive gels suffer collagen molecule damage after irradiation sterilization, affecting their thermosensitive properties. Furthermore, the preparation process is costly and storage conditions are limited, making industrial production difficult.

Method used

Gallic acid or tannic acid is used as an irradiation protectant. Decellularized matrix freeze-dried fibers are prepared by freeze-drying and irradiation sterilization combined with thermal cross-linking. The fibers are then mixed with a sterile solvent to form a decellularized matrix thermosensitive gel, which ensures that the fibers are cured at physiological temperature and enhances their strength.

Benefits of technology

It effectively protects the structure of collagen, improves the curing speed and strength of temperature-sensitive gel, enables room temperature storage and industrial production, shortens surgical time, and reduces costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924676A_ABST
    Figure CN118924676A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of medical biological materials, and relates to acellular matrix temperature-sensitive gel as well as a preparation method and application thereof. A preparation method of the acellular matrix freeze-dried fiber comprises the following steps: adding gallic acid or tannic acid into an acellular matrix stock solution, and carrying out a primary cross-linking reaction; carrying out freeze drying on the material subjected to primary crosslinking; carrying out irradiation sterilization on the freeze-dried material by adopting an irradiation dose of 8-15kGy; and carrying out thermal crosslinking on the irradiated and sterilized material to obtain the product. The temperature-sensitive performance of the acellular matrix temperature-sensitive gel can be effectively protected, and it is ensured that the acellular matrix temperature-sensitive gel can be solidified to form in-situ gel after being injected into a human body; meanwhile, the strength of the acellular matrix gel can be enhanced, the curing time is effectively shortened, enough time is provided for tissue repair, and the operation frequency of clinical surgery is reduced. And normal-temperature storage is realized, the operation cost is low, and industrial production is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medical biomaterials and relates to a decellularized matrix thermosensitive gel and a preparation method and application thereof. Background Art

[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Decellularized matrix thermosensitive gel is a temperature-sensitive gel system that utilizes the self-assembly ability of collagen, and its physical state can be regulated by temperature changes. Generally, decellularized matrix thermosensitive gel is a viscous liquid below 34°C, and in situ gel will form in the body temperature range (34-40°C). It can be freely loaded with drugs of various properties. After being administered in the form of a solution, a sol-gel phase transition can occur at the medication site under external temperature stimulation, and the formed gel can release drugs well.

[0004] Implantable thermosensitive gels must be sterilized, and common sterilization techniques include chemical sterilization, dry heat sterilization, moist heat sterilization, ethylene oxide sterilization, irradiation sterilization, and filtration sterilization. However, since the decellularized matrix thermosensitive gel is sensitive to heat, the existing technology (e.g., CN2022101942541) preferentially adopts aseptic processing or filtration sterilization, but the cost is high, the risk is high, and it is not conducive to large-scale production; and the prepared collagen gel is liquid and can only be stored at 0-10°C, and the storage conditions are limited. Radiation sterilization is the process of killing microorganisms using gamma rays, X-rays with energy less than 5MeV, or electron beams below 10MeV. Current radiation sterilization mostly uses gamma rays emitted by a 60Co source. Compared with other sterilization methods, irradiation sterilization has the following advantages: strong penetration, the sterilization effect is not affected by temperature and pressure, the sterilization performance is stable, and there is no chemical residue.

[0005] According to the inventors' research, there is no decellular matrix thermosensitive gel that has been sterilized by irradiation sterilization, because although irradiation sterilization can make the decellular matrix thermosensitive gel SAL ≤ 10 -6 However, after irradiation, the liquid decellularized matrix thermosensitive gel causes ionization and excitation of water molecules, generating highly reactive free radicals such as hydroxyl free radicals, hydrated electrons and hydrogen atoms with strong oxidative activity. These free radicals can cause various damages to proteins, destroy chemical bonds, and cause collagen protein molecules to cross-link, polymerize, and break peptide chains, making the decellularized matrix thermosensitive gel separate into a non-uniform solution. Ultimately, the thermosensitive properties of the decellularized matrix thermosensitive gel are affected, that is, after injection into the use site, the in-situ gel will not form at physiological temperature. Summary of the invention

[0006] In order to solve the deficiencies of the prior art, the purpose of the present invention is to provide a decellular matrix thermosensitive gel and a preparation method and application, which can effectively protect the thermosensitive properties of the decellular matrix thermosensitive gel and ensure that it can be solidified into an in-situ gel after being injected into the body; at the same time, the present invention can also enhance the strength of the decellular matrix gel, effectively shorten the solidification time, provide sufficient time for tissue repair, and reduce the number of clinical surgical operations. It realizes room temperature storage, low operating costs, and industrialized production.

[0007] In order to achieve the above object, the technical solution of the present invention is:

[0008] On the one hand, a method for preparing freeze-dried fibers of acellular matrix comprises adding gallic acid or tannic acid to a decellular matrix stock solution in a mass ratio of 0.01 to 0.2:1 of gallic acid or tannic acid to the decellular matrix, and performing a primary cross-linking reaction; freeze-drying the material after the primary cross-linking; irradiating and sterilizing the freeze-dried material with an irradiation dose of 8 to 15 kGy; and thermally cross-linking the irradiated and sterilized material to obtain the fiber;

[0009] Among them, the thermal cross-linking time does not exceed 60h.

[0010] In another aspect, a decellularized matrix freeze-dried fiber is obtained by the above preparation method.

[0011] In a third aspect, a method for preparing a decellular matrix thermosensitive gel is provided, wherein 5 to 50 mg of the decellularized matrix freeze-dried fiber is added per milliliter of sterile solvent, and the decellularized matrix freeze-dried fiber is mixed with the sterile solvent to obtain the thermosensitive gel.

[0012] In a fourth aspect, a decellularized matrix thermosensitive gel comprises the above-mentioned decellularized matrix freeze-dried fiber and a sterile solvent, wherein the ratio of the decellularized matrix freeze-dried fiber to the sterile solvent is 5 to 50:1, mg / mL.

[0013] A fifth aspect is a use of the above-mentioned decellularized matrix thermosensitive gel as a carrier in the preparation of drugs.

[0014] The beneficial effects of the present invention are:

[0015] (1) Since irradiation sterilization can cause the intramolecular peptide bond breakage and intermolecular cross-linking of the decellularized matrix thermosensitive gel collagen, resulting in changes in the secondary structure, tertiary structure, and quaternary structure of the collagen, thereby reducing the self-assembly ability of the collagen, the present invention adds gallic acid or tannic acid as an irradiation protectant in the thermosensitive gel. Under the corresponding irradiation dose and mass ratio, the characteristic bands of collagen can be clearly displayed, indicating that the a1 chain and a2 chain of the collagen in the product are not destroyed, and the triple helix structure is protected. Gallic acid is naturally non-toxic, which can greatly simplify the process of eluting the cross-linking agent of the decellularized matrix freeze-dried fiber, improve the preparation efficiency, and reduce the elution cost.

[0016] (2) The prior art usually uses heat crosslinking first and then irradiation sterilization, while the present invention uses irradiation sterilization first and then heat crosslinking, which greatly improves the temperature-sensitive properties of the decellularized matrix thermosensitive gel, effectively shortens the curing time, and enhances the strength of the decellularized matrix thermosensitive gel.

[0017] (3) The decellularized matrix thermosensitive gel product provided by the present invention realizes sterilization by irradiation sterilization. Compared with aseptic processing or aseptic filtration sterilization, the provided freeze-drying process, irradiation sterilization, cross-linking process and preparation method are simple and feasible, with mild production conditions, no need for aseptic processing and Class 100 environmental control, good reproducibility, strong controllability, and suitable for large-scale industrial production. A decellularized matrix thermosensitive gel that can be effectively protected during irradiation is obtained, ensuring that it can be solidified to form an in-situ gel when injected into the use site (34-40°C).

[0018] (4) The present invention utilizes the thermosensitive properties of the decellularized matrix thermosensitive gel to achieve injection at room temperature, can quickly fill irregular shaped spaces, and rapidly solidify at physiological temperature (within 10 minutes), thereby improving the feasibility of clinical operations and shortening surgical time. The solidifiable feature enables the gel to be retained at the lesion site.

[0019] (5) The present invention packages the freeze-dried fibers of the decellularized matrix separately from the solvent, thus breaking the limitation of low-temperature storage of the thermosensitive gel of the decellularized matrix. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.

[0021] Figure 1 This is a picture of freeze-dried fibers and solvent materials of the decellularized matrix prepared in the experimental example of the present invention;

[0022] Figure 2 This is a diagram showing the appearance of the thermosensitive decellularized matrix gel prepared in the experimental example of the present invention;

[0023] Figure 3 The SDS-PAGE images of the marker, standard substance, and comparative example JL group in the experimental examples of the present invention are shown in FIG.

[0024] Figure 4 The SDS-PAGE patterns of the marker, Example BD group, and Comparative Example R group in the experimental examples of the present invention;

[0025] Figure 5 The SDS-PAGE images of the marker, Example EF group, Comparative Example OR and T group in the experimental examples of the present invention are shown. DETAILED DESCRIPTION

[0026] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.

[0027] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.

[0028] As introduced in the background technology, in the preparation process of decellularized matrix thermosensitive gel, sterilization by irradiation sterilization can damage the decellularized matrix, and ultimately affect the thermosensitive properties of the decellularized matrix thermosensitive gel. In order to solve the above technical problems, the present invention proposes a decellularized matrix thermosensitive gel and a preparation method and application.

[0029] A typical embodiment of the present invention provides a method for preparing freeze-dried fibers of acellular matrix, wherein gallic acid or tannic acid is added to a decellular matrix stock solution at a mass ratio of 0.01 to 0.2:1 of gallic acid or tannic acid to decellularized matrix, and a primary cross-linking reaction is performed; the material after the primary cross-linking is freeze-dried; the freeze-dried material is irradiated and sterilized with an irradiation dose of 8 to 15 kGy; the irradiated and sterilized material is thermally cross-linked to obtain;

[0030] Among them, the thermal cross-linking time does not exceed 60h.

[0031] The invention adopts gallic acid or tannic acid containing multiple active functional groups such as hydroxyl group and carboxyl group in the structure, which can inhibit the activity of hydroxyl radicals, remove hydroxyl radicals and superoxide anion radicals, and has a strong radiation protection effect. At the same time, gallic acid or tannic acid has the characteristics of natural non-toxicity, anti-oxidation, antibacterial, and easy product availability, and is more suitable as a biological cross-linking agent in the fields of food, daily chemicals, and medicine.

[0032] In some embodiments, the mass ratio of gallic acid or tannic acid to the decellularized matrix is ​​0.01:1, and the irradiation dose is 8 kGy. Studies have shown that under these conditions, the prepared decellularized matrix thermosensitive gel can be better solidified at 34-40°C and sterilized.

[0033] In some embodiments, the mass ratio of gallic acid or tannic acid to the decellularized matrix is ​​0.02 to 0.1: 1. Studies have shown that under such conditions, the prepared decellularized matrix thermosensitive gel can be better ensured to solidify at 34 to 40° C. and be sterile.

[0034] In some embodiments, the mass ratio of gallic acid or tannic acid to acellular matrix is ​​0.02 to 0.1:1, and the irradiation dose is 10 to 12 kGy. Under this condition, the curing time is shorter, which is more conducive to improving the feasibility of clinical operation and shortening the operation time. When considering the temperature-sensitive properties, initial contamination bacteria control and low cost, the irradiation dose is 11 to 12 kGy, which has a better effect.

[0035] In some embodiments, the mass ratio of gallic acid or tannic acid to acellular matrix is ​​0.02 to 0.1:1, and the thermal cross-linking time is 24 to 48 hours. Under this condition, especially when the thermal cross-linking time is 36 to 48 hours, the curing time is shorter, which is more conducive to improving the feasibility of clinical operation and shortening the operation time.

[0036] Especially when the mass ratio of gallic acid or tannic acid to the decellularized matrix is ​​0.02-0.1:1, the irradiation dose is 10-12 kGy, and the thermal cross-linking time is 24-48 h (especially the thermal cross-linking time is 36-48 h), the curing time is shorter.

[0037] In some embodiments, the temperature of the primary cross-linking reaction is 20-30° C., and the reaction time is 2-24 hours, preferably 5-7 hours.

[0038] In some embodiments, a sodium hydroxide solution is used to adjust the pH to 4-6 to terminate the primary cross-linking reaction.

[0039] In some embodiments, freeze drying includes a pre-freezing process and a sublimation drying process. Specifically, the freeze drying procedure is shown in the following table:

[0040]

[0041] In some embodiments, the freeze-dried material is added to a breathable bottle and then thermally cross-linked. The breathable bottle is provided with a breathable through hole, and a 0.10-0.22 μm antibacterial film is provided in the breathable through hole. The breathable bottle is, for example, a vial with a breathable bottle cap, and the breathable bottle cap is composed of a 0.10-0.22 μm antibacterial film and a polytetrafluoroethylene cap. The purpose of thermal cross-linking in a breathable bottle is to prevent microorganisms from entering the vial during the cross-linking process, thereby serving as a sterile barrier function. Specifically, a 0.10-0.22 μm antibacterial film is provided in the breathable bottle, which not only realizes cross-linking, but also can effectively prevent external bacteria from entering the vial. The present invention realizes a good sterile barrier, so that the product remains sterile during the validity period.

[0042] In some embodiments, the temperature of thermal crosslinking is 50-80° C. Specifically, the procedure of thermal crosslinking is first heated to 45-55° C. for 0.4-0.6 h, and then heated to 60-80° C. for crosslinking. The time of thermal crosslinking specifically refers to the time of crosslinking at a temperature of 60-80° C.

[0043] After the sealing is performed by heat cross-linking, the product can be stored at a temperature below 25° C. for a period of 3 years.

[0044] In some embodiments, the process for preparing the decellularized matrix stock solution is as follows: mechanically removing large pieces of fat from the peritoneum, skin or small intestinal mucosa (SIS) (preferably pig peritoneum) from mammals such as pigs, cows, dogs, sheep, rabbits and mice (preferably calves and piglets), washing with water to remove immunogenic substances such as blood, freeze-drying, defatting, and enzymatic hydrolysis to obtain a decellularized matrix stock solution with a mass fraction of 0.5% to 2% and a pH of 2.0 to 3.5.

[0045] Another embodiment of the present invention provides a cell-freeze-dried matrix fiber obtained by the above-mentioned preparation method.

[0046] A third embodiment of the present invention provides a method for preparing a decellularized matrix thermosensitive gel, comprising adding 5 to 50 mg of the decellularized matrix freeze-dried fiber per milliliter of sterile solvent, and mixing the decellularized matrix freeze-dried fiber with the sterile solvent to obtain the thermosensitive gel.

[0047] In some embodiments, the sterile solvent is phosphate buffered saline (PBS) having a pH of 7.2 to 7.4 (7.4).

[0048] In some embodiments, the sterile solvent is sterilized by irradiation.

[0049] A fourth embodiment of the present invention provides a decellularized matrix thermosensitive gel, comprising the above-mentioned decellularized matrix freeze-dried fibers and a sterile solvent, wherein the ratio of the decellularized matrix freeze-dried fibers to the sterile solvent is 5 to 50:1, mg / mL.

[0050] In some embodiments, the gel is a sol liquid at a temperature of 0-34°C and solidifies into a solid gel at a physiological temperature (34-40°C).

[0051] A fifth embodiment of the present invention provides a use of the above-mentioned acellular matrix thermosensitive gel as a carrier in the preparation of drugs.

[0052] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the following experimental examples are provided in combination with specific embodiments and comparative examples to illustrate the technical solution of the present invention in detail.

[0053] Experimental Example 1 Preparation of Decellularized Matrix Thermosensitive Gel

[0054] 1. Preparation of Freeze-dried Acellular Matrix Fibers

[0055] 38 pieces of porcine peritoneum were subjected to mechanical removal of large pieces of fat, water washing to remove large pieces of fat, water washing to remove immunogenic substances such as blood, freeze-drying, defatting, and enzymatic hydrolysis in sequence to obtain a decellularized matrix stock solution with a mass fraction of 1% and a pH of 2.0. Then they were randomly divided into 22 groups, labeled as AV groups, each with 500 mL. The specific treatment methods of each group are detailed in Table 1. Gallic acid was added to the obtained decellularized matrix stock solution, and the cross-linking reaction was carried out at 25°C for 6 hours; the pH value of the cross-linking reaction solution was adjusted to 6 with a mass fraction of 1% sodium hydroxide solution to terminate the cross-linking reaction; the filling volume was adjusted, and 5 mL of the above decellularized matrix solution was filled into a vial; and it was moved to the freeze-drying chamber of the freeze dryer for freeze drying. The freeze-drying technology includes pre-freezing and gradient sublimation drying, and the specific operating conditions are as follows:

[0056]

[0057] After freeze-drying, the vial is taken out and capped with a 0.22 μm breathable cap; then irradiation sterilization is performed, and the irradiation sterilized product is cross-linked according to the thermal cross-linking procedure, as shown in the following table:

[0058] Temperature / ℃ Keep Time 50 0.5h 70 X

[0059] After cross-linking, the vial containing the freeze-dried fibers of the decellularized matrix was capped with an airtight seal and stored at a temperature below 25°C.

[0060] Table 1 Treatment methods of samples in each group

[0061]

[0062]

[0063] 2. Preparation of Solvent

[0064] A phosphate buffer solution (PBS) with a pH of 7.4 was prepared, and after preparation, it was sterilized by irradiation to obtain a sterile solvent, which was stored below 25°C.

[0065] 3. Preparation of Decellularized Thermosensitive Matrix Gel

[0066] The freeze-dried fibers of the decellularized matrix prepared above and the sterile solvent are respectively encapsulated as a thermosensitive gel product of the decellularized matrix, such as Figure 1 When used, the freeze-dried fibers of the decellularized matrix and the sterile solvent are mixed at a ratio of 50 mg:5 mL to obtain the thermosensitive decellularized matrix gel.

[0067] Experimental Example 2 Appearance Status

[0068] The thermosensitive gel of the decellularized matrix obtained in each group of Experimental Example 1 was placed in a 37°C water bath for 24 hours, and the solidification was observed and recorded by visual inspection. Figure 2 and Table 2.

[0069] Table 2 Curing experiments of each experimental group

[0070]

[0071]

[0072] From the results in Table 2, it can be seen that the decellularized matrix thermosensitive gel prepared in the comparative example JN group tolerates a radiation dose of ≤5 kGy when gallic acid is not added; the decellularized matrix thermosensitive gel prepared in the example A and the comparative example OQ group tolerates a radiation dose of ≤8 kGy when the mass ratio of gallic acid added is 0.01; the decellularized matrix thermosensitive gel prepared in the example BD and the comparative example R group tolerates a radiation dose of ≤15 kGy when the mass ratio of gallic acid added is 0.02; the decellularized matrix thermosensitive gel prepared in the example GI and the comparative example V group tolerates a radiation dose of ≤15 kGy when the mass ratio of gallic acid added is 0.1; in summary, when the mass ratio of gallic acid to decellularized matrix in the decellularized matrix gel product is 0.01:1, the radiation dose is 8 kGy, or when the mass ratio of gallic acid to decellularized matrix in the decellularized matrix gel product is 0.02-0.1:1, the radiation dose is 8-15 kGy. The difference between the decellularized matrix thermosensitive gels prepared in Example C, E, F groups and Comparative Example S group is that the cross-linking time is different. The product can be gelled when the cross-linking time is 24 to 48 hours, and the product cannot be gelled when the cross-linking time exceeds 60 hours; the difference between Comparative Example T and Example C is that the freeze-drying procedure is not performed, and the product cannot be gelled; the difference between Comparative Example U and Example C is that the cross-linking procedure is not performed, and the product can be gelled.

[0073] Experimental Example 3 Curing Time

[0074] The decellularized matrix thermosensitive gel obtained in each group of Experimental Example 1 was placed in a 37° C. water bath to keep warm, and the solidification time was recorded.

[0075] Table 3 Curing time of each experimental group

[0076]

[0077] From the results in Table 3, it can be seen that the decellularized matrix thermosensitive gel prepared in the comparative example JN group can withstand a radiation dose of ≤5 kGy when gallic acid is not added, and the product is destroyed when it exceeds 8 kGy; the decellularized matrix thermosensitive gel prepared in the example A and the comparative example OQ group can withstand a radiation dose of ≤8 kGy when the mass ratio of gallic acid added is 0.01 and the thermal crosslinking is performed for 24 hours, and can be cured in 10 minutes; the decellularized matrix thermosensitive gel prepared in the example BD and the comparative example R group can withstand a radiation dose of ≤15 kGy when the mass ratio of gallic acid added is 0.02 and the thermal crosslinking is performed for 24 hours, and the gelation time is significantly increased when the radiation dose is 15 kGy; the decellularized matrix thermosensitive gel prepared in the example GI and the comparative example V group can withstand a radiation dose of ≤15 kGy when the mass ratio of gallic acid added is 0.1 and the thermal crosslinking is performed for 24 hours, and can be cured in 10 minutes. In summary, it can be concluded that the protective effect of the decellularized matrix in the decellularized matrix gel product is obvious under the radiation dose of 8-15 kGy, indicating that gallic acid has a strong protective function, and with the increase of the mass ratio of gallic acid to decellularized matrix, the radiation dose that the decellularized matrix thermosensitive gel product can withstand is also greater.

[0078] The difference between the thermosensitive gels of decellularized matrix prepared by Example C, E, F and Comparative Example S is that the crosslinking time is different. The product can be gelled when crosslinked for 24 to 48 hours, and the gelation time is shortened as the crosslinking time increases, indicating that proper crosslinking treatment can enhance the thermosensitive gelation strength of the decellularized matrix matrix. However, when the crosslinking time exceeds 60 hours, the product does not dissolve and gelation cannot be achieved, indicating excessive crosslinking; the difference between Comparative Example T and Example C is that the freeze-drying procedure is not performed, and the product cannot be gelled, indicating that the thermosensitive gel product of the decellularized matrix can enhance the protective effect after freeze-drying; the difference between Comparative Example U and Example C is that the crosslinking procedure is not performed, and the product can be gelled, but the gelation time is longer than that of Group C, which also indicates that crosslinking can enhance the thermosensitive gelation of the product. The decellularized matrix thermosensitive gel product prepared in Example C can be solidified within 10 minutes under 37°C water bath conditions, indicating that the thermosensitive properties of the decellularized matrix thermosensitive gel can be injected at room temperature, can quickly fill irregular shaped spaces, and can be rapidly solidified at physiological temperature (within 10 minutes), thereby improving the feasibility of clinical operations and shortening operation time. The curable feature can enable the gel to be retained at the lesion site.

[0079] Experimental Example 4 Sterility Test

[0080] According to the direct inoculation method in the sterility test method 1101 of the Pharmacopoeia of the People's Republic of China, Staphylococcus aureus was selected as the positive control bacteria for sterility testing.

[0081] Preparation of test samples: Direct inoculation method was used. Each sample was reconstituted with 3 mL of the corresponding sterile culture medium (temperature not exceeding 45°C). Each sample was added into 30 mL of thioglycollate fluid culture medium and trypticase soytone liquid culture medium, respectively, and 2 tubes were prepared for each.

[0082] Negative control: Take 1 mL of sterile sodium chloride-peptone buffer at pH 7.0 and inoculate it into 30 mL of thioglycollate fluid culture medium, inoculating 1 tube.

[0083] Positive control: Take another tube of thioglycollate fluid culture medium containing the test sample, and add 1 mL of Staphylococcus aureus suspension to the culture medium to prepare 1 tube. Culture for 14 days, including thioglycollate fluid culture medium at 30-35°C, trypticase soy liquid culture medium at 20-25°C, and the positive control tube for 5 days.

[0084] Table 4 Sterility test results of each experimental group

[0085]

[0086]

[0087] From the results in Table 4, it can be seen that the sterility of the decellular matrix thermosensitive gel prepared in each embodiment and comparative example cannot be guaranteed when the irradiation dose is ≤5kGy. Although the sterility of the product can be guaranteed when the irradiation dose is 8kGy, the control of initial contamination bacteria is relatively strict. Therefore, from the perspective of temperature-sensitive properties, initial contamination bacteria control and low cost, the irradiation dose of the decellular matrix thermosensitive gel should be ≥11kGy.

[0088] Experimental Example 5 Identification of Type I Collagen

[0089] Accurately weigh 5 mg of each sample in Experimental Example 1, add 8 mL of water and 2 mL of SDS sample buffer (5×), mix, heat in a 100°C water bath for 5 min to 10 min to denature the protein, and centrifuge (650g, 5 min to 10 min). Follow the method specified in Method 5 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) in 0541 of the "Pharmacopoeia of the People's Republic of China (Volume 4)" (2020 edition), using SDS-polyacrylamide gel electrophoresis: the separation gel concentration is 10%, and the sample volume is 10 μL to 20 μL. The results are detailed in Figures 3 to 5 .

[0090] Depend on Figure 3It can be seen that compared with the standard product, when gallic acid is not added, the decellularized matrix thermosensitive gel products prepared by comparative examples J to L can clearly show the characteristic collagen bands under the condition of irradiation dose ≤5kGy, but compared with the non-irradiated product, the collagen bands of the 5kGy product are slightly weaker, but the characteristic bands disappear after irradiation at 8kGy, indicating that the a1 and a2 chains in the product are destroyed by irradiation and the triple helix structure is destroyed.

[0091] Depend on Figure 4 It can be seen that when gallic acid is added, the decellularized matrix thermosensitive gel products prepared in Example Groups B to D and Comparative Example Group R can clearly show characteristic collagen bands under the condition of an irradiation dose of ≤15 kGy, indicating that the a1 and a2 chains in the products are not destroyed and the triple helix structure is protected.

[0092] Depend on Figure 4 and Figure 5 It can be seen that the characteristic collagen bands of the decellular matrix thermosensitive gel products prepared in the comparative examples P and Q groups all disappeared under the condition of irradiation dose of 11 to 15 kGy, indicating that the a1 and a2 chains in the products were destroyed, and the triple helical structure was destroyed, while the triple helical structure of the comparative examples O, R, and Example groups B to F was protected, indicating that gallic acid has a protective function, and as the mass ratio of gallic acid to decellularized matrix increases, the irradiation dose that the decellularized matrix thermosensitive gel product can withstand is also greater. The difference between comparative example T and Example C is that the freeze-drying procedure was not performed, and solid-liquid separation occurred under the condition of irradiation dose of 11 kGy, the thermosensitive characteristics disappeared, and the characteristic collagen bands were significantly weakened, indicating that the protective effect of the decellularized matrix thermosensitive gel product was significantly improved after freeze-drying, and the radiation resistance was improved.

[0093] Based on Experimental Examples 2 to 5, the factors such as the added gallic acid content, irradiation dose, cross-linking time, and freeze-drying procedure are comprehensively considered to affect the solidification, sterile state, and collagen structure of the prepared decellularized matrix thermosensitive gel. Considering the thermosensitive properties, initial contamination bacteria control, and low cost, Example C is the best example.

[0094] Experimental Example 6 Accelerated Stability Test

[0095] The accelerated aging equivalent is 3 years (1095 days), and the accelerated aging condition is set to a temperature of 45±2°C. The accelerated aging time is calculated using the simplified accelerated aging formula:

[0096]

[0097] AAT: accelerated aging time;

[0098] RT: real-time aging time;

[0099] Q10: Aging coefficient when the temperature rises or falls by 10°C;

[0100] T AA : Accelerated aging temperature;

[0101] T RT : Temperature under normal storage conditions.

[0102] Q 10 Generally, 2.0 is selected, TRT is selected as 25°C, and the simplified formula is obtained through accelerated aging:

[0103]

[0104] That is: put the sample into the stability test box and accelerate aging at 45±2℃ for 274 days, which is equivalent to real-time aging at 25℃ for 3 years.

[0105] Group settings: Group 1: The freeze-dried fibers of the decellularized matrix in Example C and the solvent were stored separately and placed in a 25°C stability test box; Group 2: The freeze-dried fibers of the decellularized matrix in Example C and the solvent were mixed at a ratio of 50 mg:5 mL and placed in a 25°C stability test box; Group 3: The freeze-dried fibers of the decellularized matrix in Example C and the solvent were mixed at a ratio of 50 mg:5 mL and placed in a 4°C stability test box. Samples were taken from the three groups at the end of each month to test the temperature sensitivity.

[0106] Experimental results: Group 1 can be stored at 25°C for 36 months and retain its thermosensitive properties, while Group 2 loses its thermosensitive properties after one month of storage, and Group 3 loses its thermosensitive properties after 17 months of storage.

[0107] It is shown that the freeze-dried fiber preparation of the decellularized matrix using vacuum freeze-drying technology improves the stability and breaks the limitation of low-temperature storage of the thermosensitive gel of the decellularized matrix.

[0108] Experimental Example 7: Redissolution test of freeze-dried fibers of acellular matrix

[0109] The freeze-dried fibers of the decellularized matrix were mixed with the solvent at a ratio of 50 mg:5 mL, and the dissolution was visually inspected.

[0110] Table 5 Redissolution of freeze-dried fibers from acellular matrix

[0111]

[0112] From the results in Table 5, it can be seen that the difference between the thermosensitive gels of decellularized matrix prepared in Examples C, E, and F and Comparative Example S is that the crosslinking time is different. When the crosslinking time is 24 to 48 hours, the product re-dissolution time is acceptable, but when the crosslinking time exceeds 60 hours, a large amount of insoluble matter appears in the product. This shows that the thermosensitive gel of decellularized matrix prepared by the present invention can quickly realize the re-dissolution of the freeze-dried fibers of the decellularized matrix and the solvent, is easy to operate, and improves the feasibility of clinical operation.

[0113] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing freeze-dried acellular matrix fibers, characterized in that: According to the mass ratio of gallic acid or tannic acid to decellularized matrix of 0.01 to 0.2:1, gallic acid or tannic acid is added to the decellularized matrix stock solution to perform a primary cross-linking reaction; freeze-drying the material after the primary cross-linking; irradiating and sterilizing the freeze-dried material with an irradiation dose of 8 to 15 kGy; and thermally cross-linking the irradiated and sterilized material to obtain; Among them, the thermal cross-linking time does not exceed 60h.

2. The method for preparing the freeze-dried acellular matrix fiber according to claim 1, characterized in that: The mass ratio of gallic acid or tannic acid to acellular matrix was 0.01:1, and the irradiation dose was 8 kGy; or, the mass ratio of gallic acid or tannic acid to acellular matrix is ​​0.02 to 0.1:1; Or, the mass ratio of gallic acid or tannic acid to the decellularized matrix is ​​0.02 to 0.1:1, and the irradiation dose is 10 to 12 kGy; preferably, the irradiation dose is 11 to 12 kGy; Alternatively, the mass ratio of gallic acid or tannic acid to the decellularized matrix is ​​0.02 to 0.1:1, and the thermal cross-linking time is 24 to 48 hours; preferably, the thermal cross-linking time is 36 to 48 hours.

3. The method for preparing the freeze-dried acellular matrix fiber according to claim 1, characterized in that: The temperature of the primary cross-linking reaction is 20-30°C, and the reaction time is 2-24 hours; the reaction time is preferably 5-7 hours; Alternatively, a sodium hydroxide solution is used to adjust the pH to 4 to 6 to terminate the primary cross-linking reaction.

4. The method for preparing freeze-dried acellular matrix fibers according to claim 1, characterized in that: Freeze drying includes a pre-freezing process and a sublimation drying process; preferably, the freeze drying procedure is shown in the following table: Alternatively, the freeze-dried material is added to a breathable bottle and then thermally cross-linked, wherein the breathable bottle is provided with a breathable through hole, and a 0.10-0.22 μm antibacterial film is provided on the breathable through hole; Alternatively, the temperature of thermal crosslinking is 50-80°C; preferably, the procedure of thermal crosslinking is: first heating to 45-55°C for 0.4-0.6h, then heating to 60-80°C for crosslinking.

5. A decellularized matrix freeze-dried fiber, characterized in that: Obtained by the preparation method according to any one of claims 1 to 4.

6. A method for preparing a decellularized matrix thermosensitive gel, characterized in that: The decellularized matrix freeze-dried fibers are mixed with the sterile solvent at a ratio of 5 to 50 mg per milliliter of the sterile solvent to obtain the decellularized matrix freeze-dried fibers.

7. The method for preparing the decellularized matrix thermosensitive gel according to claim 6, characterized in that: The sterile solvent is a phosphate buffer solution with a pH of 7.2 to 7.4; Alternatively, the sterilization method of the sterile solvent is irradiation sterilization.

8. A decellularized matrix thermosensitive gel, comprising The above-mentioned decellularized matrix freeze-dried fiber and the sterile solvent, the ratio of the decellularized matrix freeze-dried fiber to the sterile solvent is 5 to 50:1, mg / mL.

9. The acellular matrix thermosensitive gel according to claim 8, characterized in that: It is a sol liquid at a temperature of 0 to 34°C and solidifies into a solid gel at physiological temperature.

10. Use of the decellularized matrix thermosensitive gel according to claim 8 or 9 as a carrier in the preparation of drugs.